We evaluated the feasibility of planning stereotactic body radiotherapy (SBRT) for large central early-stage non-small cell lung cancer with a tri-cobalt-60 (tri-(60)Co) system equipped with real-time magnetic resonance imaging (MRI) guidance, as compared to linear accelerator (LINAC)-based SBRT. In all, 20 patients with large central early-stage non-small cell lung cancer who were treated between 2010 and 2015 with LINAC-based SBRT were replanned using a tri-(60)Co system for a prescription dose of 50Gy in 4 fractions. Doses to organs at risk were evaluated based on established MD Anderson constraints for central lung SBRT. R100 values were calculated as the total tissue volume receiving 100
作者:Catherine, Merna;Jean-Claude M, Rwigema;Minsong, Cao;Pin-Chieh, Wang;Amar U, Kishan;Argin, Michailian;James, Lamb;Ke, Sheng;Nzhde, Agazaryan;Daniel A, Low;Patrick, Kupelian;Michael L, Steinberg;Percy, Lee
来源:Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2016 年 41卷 1期